Inflammation couples ICAM1–ITGB2 myeloid adhesion to checkpoint restraint: a two-layer model of immune evasion in EBV-associated gastric carcinoma
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This dataset contains the underlying experimental source data and original images supporting the revised study entitled “Inflammation couples ICAM1–ITGB2 myeloid adhesion to checkpoint restraint: a two-layer model of immune evasion in EBV-associated gastric carcinoma.” The updated data package is organized into seven folders according to experimental category: 1. **Adhesion_Figure:** Source data and images from tumor–macrophage adhesion assays, including ICAM1/CD18 antibody-blockade experiments. 2. **flow:** Flow cytometry data and associated analyses of tumor-cell ICAM1/PD-L1 expression and intratumoral immune-cell populations, including myeloid subsets, CD8⁺ T cells, and granzyme B (GZMB) expression. 3. **MFC615:** Source data from the immunocompetent MFC syngeneic mouse experiments, including tumor growth measurements, endpoint tumor weights, and excised tumor images. 4. **mIF:** Multiplex immunofluorescence images documenting tumor–immune spatial organization in endpoint mouse tumor sections. These images provide descriptive spatial evidence. 5. **qPCR_ICAM1:** Original quantitative PCR data and associated analyses of ICAM1 expression. 6. **qPCR_NFkB_TPCA1:** Quantitative PCR source data from TNF-α stimulation and TPCA-1-mediated NF-κB inhibition experiments. 7. **WB:** Original western blot images and related source data supporting analyses of NF-κB pathway activation and ICAM1 protein expression. These materials support the experimental findings reported in the revised manuscript, including inflammatory signaling, tumor–macrophage adhesion, immune-cell remodeling, and combination treatment with ICAM1 and PD-1 blockade. The MFC mouse experiments represent an EBV-negative, immunocompetent proof-of-concept model. Publicly available bulk, single-cell, and spatial transcriptomic datasets are not independently redeposited here and can be accessed through their original public repositories.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Cell Adhesion Molecules Research
Immune cells in cancer
Publication details
- Journal / source
- Mendeley Data
- Publication date
- 30 March 2026
- Language
- EN
- Document type
- Dataset